At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Apr 2000 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)